Parathyroid hormone
2011/386
Phase 3 small_molecule completed
Quick answer
Parathyroid hormone for Disruption or Dehiscence of Closure of Sternum or Sternotomy is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Disruption or Dehiscence of Closure of Sternum or Sternotomy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed